Sanofi (SNY) Total Debt (2009 - 2026)
Sanofi (SNY) posted Total Debt of $25.2 billion for Q2 2026, up 16.41% sequentially from $21.6 billion in Q4 2025, and up 8.51% YoY from $23.2 billion in Q2 2025.
Sanofi (SNY) Total Debt (2009 - 2026) Analysis & Trends
Sanofi has reported Total Debt for 18 years, with the latest figure at $25.2 billion in Q2 2026.
- Quarterly Total Debt rose 8.51% year-over-year to $25.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $25.2 billion (up 8.51% YoY) and the FY2025 annual result came in at $21.6 billion, up 26.57% from the prior year.
- Total Debt grew to $25.2 billion in Q2 2026 per SNY's latest filing, from $21.6 billion in the prior quarter.
- Over five years, Total Debt peaked at $25.2 billion in Q2 2026 and troughed at $17.1 billion in Q4 2024.
- A 5-year average of $20.9 billion and a median of $20.6 billion in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2025: Total Debt retreated 16.47% in 2022, then gained 26.57% in 2025.
- Over 5 years, Total Debt stood at $19.4 billion in 2022, then decreased by 9.17% to $17.6 billion in 2023, then retreated by 3.06% to $17.1 billion in 2024, then gained by 26.57% to $21.6 billion in 2025, then gained by 16.41% to $25.2 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $25.2 billion, $21.6 billion, and $23.2 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 29.49 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 62.75 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 28.66 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -25.96 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 25.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.19 Bn |
| Dec 31, 2025 | 21.64 Bn |
| Jun 30, 2025 | 23.22 Bn |
| Dec 31, 2024 | 17.10 Bn |
| Jun 30, 2024 | 23.41 Bn |
| Dec 31, 2023 | 17.64 Bn |
| Jun 30, 2023 | 20.62 Bn |
| Dec 31, 2022 | 19.42 Bn |
| Jun 30, 2022 | 20.28 Bn |
| Dec 31, 2021 | 23.23 Bn |
| Jun 30, 2021 | 24.28 Bn |
| Dec 31, 2020 | 26.84 Bn |
| Jun 30, 2020 | 26.14 Bn |
| Dec 31, 2019 | 27.32 Bn |
| Jun 30, 2019 | 28.65 Bn |
| Dec 31, 2018 | 28.12 Bn |
| Sep 30, 2018 | 53.50 Mn |
| Mar 31, 2018 | 33.17 Bn |
| Dec 31, 2017 | 18.37 Bn |
| Jun 30, 2017 | 20.26 Bn |